Remus Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Remus Pharmaceutical	Shree Ganesh Remed.	Anlon Healthcare
Operational Metrics
Financials
5 yr Average ROE	22.94 %	20.54 %	37.59 %
5yr average Equity Multiplier	1.87	1.34	19.54
5yr Average Asset Turnover Ratio	1.12	0.81	0.72
5yr Avg Net Profit Margin	11.07 %	19.4 %	9.13 %
Price to Book	0.0	5.06	3.47
P/E	22.92	46.48	28.69
5yr Avg Cash Conversion Cycle	37.04 Days	74.82 Days	215.12 Days
Inventory Days	36.45 Days	56.37 Days	146.25 Days
Days Receivable	65.7 Days	69.81 Days	172.55 Days
Days Payable	111.91 Days	57.45 Days	138.78 Days
5yr Average Interest Coverage Ratio	48.28	37.3	3.68
5yr Avg ROCE	25.27 %	25.4 %	16.7 %
5yr Avg Operating Profit Margin	14.8 %	28.41 %	17.87 %
5 yr average Debt to Equity	0.19	0.17	13.59
5yr CAGR Net Profit	27.88 %	29.89 %	n/a
5yr Average Return on Assets	12.5 %	15.33 %	5.99 %
Shareholdings
Promoter Holding	70.95 %	72.84 %	52.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.34 %	3.51 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Remus Pharmaceutical	Shree Ganesh Remed.	Anlon Healthcare
Product Wise Break-Up	Product Wise Break-Up Nutraceuticals 0 Finished Dosage Formulation 0 APIs 0 Others 100	-	Product Wise Break-Up Nutraceuticals 6.61 APIs 40.27 Finished Dosage Formulation 53.12